Published in J Alzheimers Dis on January 01, 2013
Metabolic profiling of Alzheimer's disease brains. Sci Rep (2013) 0.94
Periodontal disease associates with higher brain amyloid load in normal elderly. Neurobiol Aging (2014) 0.91
Glucose metabolism in normal aging and Alzheimer's disease: Methodological and physiological considerations for PET studies. Clin Transl Imaging (2013) 0.91
The unfolded protein response mediates reversible tau phosphorylation induced by metabolic stress. Cell Death Dis (2014) 0.90
Brain PET in the diagnosis of Alzheimer's disease. Clin Nucl Med (2014) 0.84
Comparing amyloid-β deposition, neuroinflammation, glucose metabolism, and mitochondrial complex I activity in brain: a PET study in aged monkeys. Eur J Nucl Med Mol Imaging (2014) 0.83
Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks. Hum Brain Mapp (2015) 0.83
Physical Activity, Mediterranean Diet and Biomarkers-Assessed Risk of Alzheimer's: A Multi-Modality Brain Imaging Study. Adv J Mol Imaging (2014) 0.79
Molecular imaging of Alzheimer disease pathology. AJNR Am J Neuroradiol (2014) 0.78
Early-Phase 11C-PiB PET in Amyloid Angiopathy-Related Symptomatic Cerebral Hemorrhage: Potential Diagnostic Value? PLoS One (2015) 0.77
Dose-dependent effects of the CRF(1) receptor antagonist R317573 on regional brain activity in healthy male subjects. Psychopharmacology (Berl) (2009) 0.81
An evaluation of MSDC-0160, a prototype mTOT modulating insulin sensitizer, in patients with mild Alzheimer's disease. Curr Alzheimer Res (2014) 0.75